In 2018, a recent large harmonization effort confirmed that a panel of CD19, CD5, CD20, CD23 and sIg kappa or lambda is usually sufficient to establish the diagnosis of CLL using peripheral blood samples [30]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.